ArticleNeurology2025
Role of the Proportional Odds Assumption for the Analysis of Ordinal Outcomes in Neurologic Trials.
Article in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Effect of Two Glasgow Outcome Scale-Extended Scoring Methods on Traumatic Brain Injury Clinical Trial Design: A TRACK-TBI Study.Journal of neurotrauma · 2026Article
- Ordinal Clinical Outcome Modeling with Temporal Validation to Support Hospital Capacity Planning During Acute Infectious Disease Burden.International journal of environmental research and public health · 2026Article
- Longitudinal Extension of the Win Odds for Ordinal Repeated Measurements.Statistics in medicine · 2026Article
- Association between obesity and neurodevelopmental delay risk in children under five years: A study from Tumbes, Peru.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ordinal scales are categories ordered by their clinical preference, such as the modified Rankin Scale and Glasgow Outcome Scale Extended. They are widely used as key outcome measures in neurologic trials. Compared with binary outcomes, ordinal scales allow a more detailed assessment of the effect of the treatment and provide more statistical power. Typically, the proportional odds (PO) model (or "shift analysis") is used to quantify the treatment effect in a common odds ratio (cOR) and to test the null hypothesis that the treatment has no effect. Clinical researchers and trialists may worry that the PO assumption will not hold and therefore decide to dichotomize the ordinal scale into a binary outcome. Here, we explain that for the purpose of testing the presence of a treatment effect, it is irrelevant whether the PO assumption holds. In fact, pretesting this assumption to decide which test to use for the treatment effect is invalid and can inflate the type I error probability. Although the PO assumption is not relevant for testing, it is definitely relevant for the purpose of describing and summarizing the treatment effect. We suggest a simple graphical check of the PO assumption as more informative than formal testing. If we are satisfied that there is no substantial violation of the PO assumption, it is reasonable to summarize the treatment effect into a single number such as the cOR. Otherwise, no single-number summary measure provides a faithful representation. We illustrate these practical considerations with 3 neurologic trials: the Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients with a Large Infarct Core (ANGEL-ASPECT) trial and the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands ([MR CLEAN], which investigated endovascular therapy in stroke) and the RESCUEicp trial (which investigated decompressive craniectomy in traumatic brain injury). We conclude with recommendations for the statistical workflow. Undue concerns about the PO assumption should not deter researchers from using ordinal scales in neurologic trials. We provide an R package
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.